The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.33
Bid: 4.26
Ask: 4.78
Change: 0.00 (0.00%)
Spread: 0.52 (12.207%)
Open: 4.33
High: 0.00
Low: 0.00
Prev. Close: 4.33
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First US patent issues for PREtec peptide products

23 Jan 2020 07:00

RNS Number : 6559A
Plant Health Care PLC
23 January 2020
 

23 January 2020

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

First US patent issues for PREtec peptide products

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets with a strong track record of successful commercialisation of new technologies, is pleased to announce the granting of the first US patent on its novel PREtec peptide technology.

 

Highlights:

- Plant Health Care has filed more than 50 patent applications worldwide for its PREtec peptide technology since 2012

- The first of these patents has now been granted by the US Patent and Trademark Office (USPTO)

- The patent provides protection for a series of PREtec peptides in a wide range of agricultural uses

- Additional patents are expected to be granted over the coming months

- The Company is planning to commercialise PREtec peptides into market opportunities worth more than $5bn

 

Plant Health Care is developing novel peptide products from the PREtec (Plant Response Elicitor) platform. These products act as 'vaccines for plants'; they stimulate the plant to defend itself from stress, such as disease and drought, leading to better quality and higher yield at harvest. Derived from natural proteins, PREtec peptides are a novel, environmentally friendly approach to protecting crops and increasing yields, compatible with mainstream agricultural practices. The Company is initially targeting market opportunities worth more than $5bn.

US patent No. 10,470,461, issued November 12, 2019, claims a large number of unique response elicitor peptides, as well as their use in combination with other agricultural products to enhance disease resistance, improve plant growth, and impart tolerance to both biotic stresses and abiotic stresses such as heat, drought, and excess soil salinity.

 

Zhongmin Wei, Ph.D., Chief Scientific Officer for Plant Health Care and inventor of the PREtec technology said, "I am pleased that the USPTO has recognized the patentability of the response elicitor peptide sequences and their use for agricultural production. This is the first of a series of patents that we expect will issue shortly. Plant Health Care is carving out a dominant patent position around the use of response elicitor peptides in agriculture."

 

Chris Richards, CEO of Plant Health Care, said, "Receiving this patent is another significant milestone in our path to bringing PREtec peptides to commercial sales. Alongside our recently announced progress at scaling up manufacture of our lead peptide, PHC279, and the exciting results shown for the control of Asian Soybean Rust (ASR) in Brazil, this further boosts our confidence about the commercial potential for PREtec based products. We are preparing to launch this novel technology directly to markets in USA, Brazil and other countries, once regulatory permits are in place."

 

 

For further information, please contact:

Plant Health Care plc

Chris Richards, CEO Tel: +1 919 926 1600

Jeff Tweedy, COO Tel: +1 919 926 1600

Arden Partners plc - Nomad and Broker

John Llewellyn-Lloyd / Dan Gee-Summons (Corporate Finance) Tel: +44 (0) 20 7614 5900

Fraser Marshall (Equity Sales)

Company website: www.planthealthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGZGZMGZFGGZZ
Date   Source Headline
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSDirectorate Change
1st Apr 20087:01 amRNSTotal Voting Rights
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results
27th Sep 20075:19 pmRNSDirector/PDMR Shareholding
27th Sep 20077:01 amRNSPlacing
24th Sep 20077:03 amRNSHalf Year Results
24th Sep 20077:02 amRNSMyconate Trial Results
31st Aug 200710:14 amRNSTotal Voting Rights
28th Aug 20071:00 pmRNSStock Award
23rd Aug 200710:14 amRNSNotice of Results
13th Aug 20074:15 pmRNSAIM Rule 26 Information
13th Aug 200711:55 amRNSHolding(s) in Company
13th Aug 20078:49 amRNSHolding(s) in Company
31st Jul 200711:39 amRNSTotal Voting Rights
27th Jul 20077:01 amRNSN-Hibit Trial Results
25th Jul 20071:38 pmRNSAdditional Listing
23rd Jul 200711:35 amRNSDirector/PDMR Shareholding
2nd Jul 20072:25 pmRNSTotal Voting Rights
27th Jun 20077:01 amRNSProduct Update
11th Jun 20075:53 pmRNSHolding(s) in Company
8th Jun 20075:03 pmRNSAGM Statement
4th Jun 20077:31 amRNSTotal Voting Rights
17th May 20077:01 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.